Corient Private Wealth
RXST icon

Corient Private Wealth’s RxSight RXST Stock Holding History

Corient Private Wealth’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$414K Buy
85,838
+54,806
+177% +$331K ﹤0.01% 2364
2026
Q1 		$8.58K Sell
31,032
-5,063
-14% -$42K ﹤0.01% 2805
2025
Q4 		$376K Buy
36,095
+5,933
+20% +$59.5K ﹤0.01% 2027
2025
Q3 		$271K Buy
+30,162
New +$265K ﹤0.01% 2187
2024
Q2 		– Sell
-4,071
Closed -$210K – 2379
2024
Q1 		$210K Sell
4,071
-5,900
-59% -$290K ﹤0.01% 2079
2023
Q4 		$402K Hold
9,971
– – ﹤0.01% 1725
2023
Q3 		$278K Hold
9,971
– – ﹤0.01% 1781
2023
Q2 		$287K Buy
+9,971
New +$222K ﹤0.01% 1721

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Corient Private Wealth's RXST Position: Q2 2026 in Review

Corient Private Wealth increased its RxSight (RXST) stake by 177% in Q2 2026, buying an estimated $331K and bringing the position to 85,838 shares worth $414K. The position accounts for ﹤0.01% of the portfolio, ranked #2364.

Corient Private Wealth first reported a position in RXST in Q2 2023 and has held it in 8 quarters since. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Corient Private Wealth held 85,838 shares of RxSight worth $414K as of Q2 2026.
  • Corient Private Wealth bought 54,806 RxSight shares in Q2 2026, an estimated $331K.
  • RxSight made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #2364 holding.
  • Corient Private Wealth first reported a position in RxSight in Q2 2023 and has held it in 8 quarters since.
  • 151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.